Technical analysis of GeneDx Holdings Corp. (WGS): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp.
Price Performance
| 1 month | -11.30% |
| 3 months | +16.23% |
| Year-to-date | -41.36% |
| 1 year | -36.54% |
| 3 years | +2197.29% |
| 5 years | -70.67% |
52-Week Range
| 52-week High | $170.87 |
| 52-week Low | $32.21 |
| Avg Volume (90d) | 834K |
Technical Indicators
| SMA 50 | $81.61 |
| SMA 200 | $78.06 |
| Beta | 2.19 |
| 30-day Volatility (annualised) | 66.3% |
| Price vs SMA 50 | -6.5% |
| Price vs SMA 200 | -2.3% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-11 | $166.95 | |
| 2025-12 | $130.06 | -22.1% |
| 2026-01 | $96.26 | -26.0% |
| 2026-02 | $79.71 | -17.2% |
| 2026-03 | $64.22 | -19.4% |
| 2026-04 | $62.89 | -2.1% |
| 2026-05 | $51.99 | -17.3% |
| 2026-06 | $68.65 | +32.0% |
| 2026-07 | $65.11 | -5.2% |
| 2026-08 | $84.81 | +30.3% |
| 2026-09 | $72.30 | -14.8% |
| 2026-10 | $76.27 | +5.5% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-10-27 | $0.07 | $123M |
| 2026-08-03 | $-0.19 | $111M |
| 2026-05-04 | $-0.06 | $112M |
| 2026-02-23 | $0.11 | $120M |
| 2025-10-28 | $0.28 | $120M |
| 2025-07-29 | $0.10 | $99M |
| 2025-04-30 | $0.11 | $85M |
Price
| Price | $76.27 |
| Market Cap | $2.3B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 8.89 |
| EV / EBITDA | -29.92 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.69 |
| Current Ratio | 3.30 |